Multiple Myeloma in Relapse
Oncology·MeSH: Multiple Myeloma
Prevalence
17.0 / 100K
Incidence
7.0 / 100K/yr
1 drug in development·1 company·5 clinical trials
Drug Pipeline by Phase
Phase 1(1)
Frequently asked questions
How many drugs are in development for Multiple Myeloma in Relapse?
BioSniper tracks 1 drug in development for Multiple Myeloma in Relapse across 1 company.
How many clinical trials target Multiple Myeloma in Relapse?
There are 5 clinical trials targeting Multiple Myeloma in Relapse tracked by BioSniper.
What is the prevalence of Multiple Myeloma in Relapse?
The estimated prevalence of Multiple Myeloma in Relapse is approximately 17.0 per 100,000 population.
Deep-dive into Multiple Myeloma in Relapse
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis